Xconomy - xconomy.com - Xconomy
General Information:
Latest News:
Syndax Pockets $26.6M For Final Stage Push With Cancer Drug 27 Aug 2013 | 04:00 pm
Ben Fidler Syndax Pharmaceuticals has spent eight years trying to show it can make existing cancer drugs work better by switching off certain enzymes implicated in tumor mutation. Now, it has landed ...
“Do or Die” Moment for Foes of Retroactive Tax in California 27 Aug 2013 | 03:30 pm
Wade Roush After a 2012 court ruling invalidated an old tax break for small-business investors, California entrepreneurs laid siege to Sacramento. They persuaded allies in the California Senate to wh...
CO Everywhere App Traces a New Way to View Neighborhoods 27 Aug 2013 | 01:00 pm
Curt Woodward Boston startup Block Avenue formed around the idea of helping people unearth information about their neighborhoods. But eventually, the young company found the real stars of the show: t...
Histogen Wins Legal Ruling in Saga of Entrepreneurial Perseverance 27 Aug 2013 | 06:40 am
Bruce V. Bigelow Back in 2011, when a federal judge in San Diego issued a summary judgment for San Diego-based Histogen in a patent dispute, CEO Gail Naughton proclaimed, “We are happy now to have th...
Colorado Innovators to Celebrate Risking and Recovering from Failure 27 Aug 2013 | 01:40 am
Michael Davidson Failure in the business world is a funny thing. Entrepreneurs who take risks and build innovative companies against long odds are celebrated, and their failures become part of their ...
SXSW Seeks Input on Cleantech, Education, Film and Music Panels 26 Aug 2013 | 10:22 pm
Angela Shah Voting is underway for panels at South By Southwest Interactive, as well as for SXSW Music, SWSW Film, and SXSWedu. More than 4,000 panel ideas have been submitted for the four conferenc...
Detroit’s Silith.IO Takes Its Mobile Collaboration Tool to Silicon Valley 26 Aug 2013 | 10:12 pm
Sarah Schmid Brian Clark, co-founder of Silith.IO, is on the adventure of a lifetime. A few weeks ago, he quit his full-time job, sold nearly everything he owned, and headed to San Francisco, his ear...
Why Good Drugs Sometimes Fail: The Bexxar Story 26 Aug 2013 | 12:01 pm
Luke Timmerman Quite a few biotech entrepreneurs go to work each day operating under the assumption that clinical trial data is king. If you put together a rock-solid dataset from a big clinical tria...
Amgen Agrees to Buy Onyx for $125 Per Share, or $10.4B 26 Aug 2013 | 03:30 am
Luke Timmerman [Updated: 6:15 pm PT] Amgen got what it wanted from Onyx Pharmaceuticals in the end. The Thousand Oaks, CA-based biotech giant (NASDAQ: AMGN) said today it has agreed to acquire South...
Garaizar Aims to Elevate Houston Angels’ Profile and Outreach 23 Aug 2013 | 10:59 pm
Angela Shah Juliana Garaizar joined the Houston Angel Network as managing director just as the group was seeking to revamp its operations and to take a more prominent role the state’s entrepreneurial...
